WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007005174) 4- (3 -HYDROXY- AND 3-AMINOMETHYL-CYCLOHEXEN-3-YLMETHYL) 1, 3-DIHYDROIMDAZOLE-2-THIONE DERIVATIVES AS ALPHA-2 ADRENERGIC AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/005174    International Application No.:    PCT/US2006/021866
Publication Date: 11.01.2007 International Filing Date: 06.06.2006
IPC:
C07D 233/84 (2006.01), A61K 31/4164 (2006.01), A61P 5/24 (2006.01), A61P 9/12 (2006.01), A61P 25/24 (2006.01), A61P 27/06 (2006.01), A61P 29/00 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive, Irvine, CA 92612 (US) (For All Designated States Except US).
CHOW, Ken [US/US]; (US) (For US Only).
HEIDELBAUGH, Todd, M. [US/US]; (US) (For US Only).
NGUYEN, Phong, X. [US/US]; (US) (For US Only)
Inventors: CHOW, Ken; (US).
HEIDELBAUGH, Todd, M.; (US).
NGUYEN, Phong, X.; (US)
Agent: JOHNSON, Brent, A.; Allergan, Inc., 2525 Dupont Drive, Irvine, CA 92612 (US)
Priority Data:
11/172,229 29.06.2005 US
Title (EN) 4- (3 -HYDROXY- AND 3-AMINOMETHYL-CYCLOHEXEN-3-YLMETHYL) 1, 3-DIHYDROIMDAZOLE-2-THIONE DERIVATIVES AS ALPHA-2 ADRENERGIC AGONISTS
(FR) AGONISTES ADRENERGIQUES ALPHA-2
Abstract: front page image
(EN)A compound is disclosed herein comprising Formulat (I); or a pharmaceutically acceptable salt or a prodrug thereof; wherein R is OH or NH2- Methods, compositions, and medicaments related thereto are also disclosed.
(FR)L'invention concerne un composé de formule (I); ou un sel pharmaceutiquement acceptable ou un promédicament de celui-ci. Dans la formule (I), R désigne OH ou NH2-. L'invention concerne également des méthodes, des compositions, et des médicaments associés à ce composé.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)